Fractional Co2 Laser Treatment of the Vulva and Vagina and the Effect of Postmenopausal Duration on Efficacy
Macrene R. Alexiades, MD, PhD
Dermatology and Laser Surgery Center of New York, Yale University School of Medicine, New York, New York
More studies are needed to assess the long‐term safety profile and clinical out- comes of lasers and energy‐based devices to treat the symptoms associated with vulvovaginal atrophy. This study evaluated a series of three fractional CO2 laser treatments to the vulva and vagina with a 1‐year follow‐ up in a postmenopausal population.
